Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-12

FDA Approved: ROSUVASTATIN — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' supplemental application for rosuvastatin (generic rosuvastatin), authorizing its marketing in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosuvastatin (rosuvastatin)

Snippet

SUPPL AP for ROSUVASTATIN (ROSUVASTATIN)